Robin Hood Ventures has completed its funding as part of the $5 Million Series A equity investment in Core Essence Orthopaedics, Inc., a medical device company based in Yardley, PA, focusing on soft tissue and skeletal repair. NewSpring Capital is leading the round through its dedicated healthcare fund, NewSpring Health Capital.
Core Essence Orthopaedics, Inc. (CE Ortho) is a privately held orthopaedic device company focused on the development, manufacture and commercialization of solutions for minimally invasive soft tissue and arthroscopic musculoskeletal repair for the extremity market. CE Ortho’s intuitive and innovative technologies are driven by increasing demands for alternatives to complicated surgical procedures. CE Ortho devices enable surgeons to build on classic and familiar surgical techniques with novel instruments and implants that simplify procedures and can be mastered quickly. The company’s proprietary technologies provide solutions to the growing volume of tendon and ligament repairs required by the active lifestyles of patients of all ages.
Website: http://www.CEOrtho.com
Robin Hood focuses on investing in early stage companies located in the Mid-Atlantic region. Portfolio companies include Aklero Process Solutions, Inc., Protez Pharmaceuticals, Bioconnect Systems, Intellifit, Paradigm Spine, Glucolight, Patria, Athleague, GlobalPrint, Power Medical Interventions (PMII), Compoze (acquired by BEA), and Etech Solutions, Inc., (Acquired by Perficient - PRFT) . As of August 2008, Robin Hood has invested in 21 companies.
Website: http://www.robinhoodventures.com
Dave Speers is an online marketing consultant and start-up junky that has worked with a wide variety of Philadelphia businesses. Dave spends most his time annoying really smart people at Indy Hall co-working collaborative.
